Literature DB >> 15802281

Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial?

O Landgren, H Andrén, B Nilsson, A Ekbom, M Björkholm.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15802281     DOI: 10.1093/annonc/mdi145

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma.

Authors:  Kenneth R Carson; Nancy L Bartlett; Jay R McDonald; Suhong Luo; Angelique Zeringue; Jingxia Liu; Qiang Fu; Su-Hsin Chang; Graham A Colditz
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

2.  Recognition of comorbid diabetes and obesity in hospital records of newly diagnosed cancer patients.

Authors:  A P Polednak
Journal:  Ann Oncol       Date:  2009-01-23       Impact factor: 32.976

3.  The role of body mass index in survival outcome for lymphoma patients: US intergroup experience.

Authors:  F Hong; T M Habermann; L I Gordon; H Hochster; R D Gascoyne; V A Morrison; R I Fisher; N L Bartlett; P J Stiff; B D Cheson; M Crump; S J Horning; B S Kahl
Journal:  Ann Oncol       Date:  2014-03       Impact factor: 32.976

4.  Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma.

Authors:  Shama Jaswal; Vanessa Sanders; Priyanka Pullarkat; Stephanie Teja; Amber Salter; Marcus P Watkins; Norman Atagu; Daniel R Ludwig; Joyce Mhlanga; Vincent M Mellnick; Linda R Peterson; Nancy L Bartlett; Brad S Kahl; Todd A Fehniger; Armin Ghobadi; Amanda F Cashen; Neha Mehta-Shah; Joseph E Ippolito
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

5.  The Impact of Obesity on Hodgkin's Lymphoma Patients Treated With Uniform Chemotherapy Protocol at Princess Noorah Oncology Center, National Guard Health Affairs, Jeddah, Saudi Arabia: Retrospective Matched Cohort.

Authors:  Alaa T Alsharif; Mohammed Aldawsari; Emad M Babateen; Meshaal A Kouther; Faisal F Aljahdali; Ahmed Absi; Taghreed Aldosary; Mohamed E Ahmed
Journal:  Cureus       Date:  2022-05-14

6.  Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.

Authors:  Ya-Jun Li; Ping-Yong Yi; Ji-Wei Li; Xian-Ling Liu; Xi-Yu Liu; Fang Zhou; Zhou OuYang; Zhong-Yi Sun; Li-Jun Huang; Jun-Qiao He; Yuan Yao; Zhou Fan; Tian Tang; Wen-Qi Jiang
Journal:  Oncotarget       Date:  2017-01-17

7.  Prognostic Impact of a Body Mass Index Decrease during First Chemotherapy in Patients with Advanced Follicular Lymphoma.

Authors:  Makoto Ito; Yasuhiko Harada; Yoshitoyo Kagami; Junji Hiraga
Journal:  Intern Med       Date:  2022-07-15       Impact factor: 1.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.